المؤلفون: Klaus Kaier, Uwe Frank

المصدر: PharmacoEconomics. 28:1123-1128

مصطلحات موضوعية: Methicillin-Resistant Staphylococcus aureus, jel:D, Drug resistance, jel:C, medicine.disease_cause, jel:I, Microbiology, Toxicology, jel:I1, Antibiotic resistance, Drug Resistance, Bacterial, medicine, Humans, Infection control, Antibacterial agent, Pharmacology, Cross Infection, jel:Z, Antimicrobial-resistance, Cephalosporins, therapeutic use, Cost-analysis, Fluoroquinolones, therapeutic use, Lincosamides, therapeutic use, Methicillin-resistant-Staphylococcus-aureus-infections, Prevention, business.industry, Health Policy, Public Health, Environmental and Occupational Health, Staphylococcal Infections, jel:I11, Methicillin-resistant Staphylococcus aureus, Anti-Bacterial Agents, Defined daily dose, jel:I18, jel:I19, Antibacterial activity, business, Externality, Hand Disinfection

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b8634d444db4565e97f4d923788c7a6
https://doi.org/10.2165/11535640-000000000-00000